Table 2 Neonatal characteristics and early neonatal outcomes of the study groups
Variable | Treatment group (n:196) | Control group (n:204) | p |
|---|---|---|---|
Gestational age at birth (weeks) | |||
34–35 | 46 (23.5) | 52 (25.5) | 0.61 |
35–36 | 71 (36.2) | 52 (25.5) | |
36–37 | 79 (40.3) | 100 (49) | |
Cesarean delivery | 140 (71.8) | 152 (74.5) | 0.54 |
Urgent | 39 (27.9) | 29 (19.1) | 0.08 |
Elective | 101 (72.1) | 123 (80.9) | |
Female gender | 79 (40.3) | 83 (40.7) | 0.93 |
Birthweight (grams) | |||
< 2500 | 41 (20.9) | 28 (13.7) | 0.05 |
≥ 2500 | 155 (79.1) | 176 (86.3) | |
Small for gestational age | 23 (11.7) | 19 (9.3) | 0.43 |
Large for gestational age | 36 (18.4) | 54 (26.5) | 0.05 |
APGAR 1 | 9 (8.25-9) | 9 (8–9) | 0.55 |
APGAR 5 | 10 (10–10) | 10 (10–10) | 0.38 |
NICU admission | 61 (31.1) | 47 (23) | 0.06 |
Hypoglycemia | 8 (4.1) | 15 (7.4) | 0.16 |
Hyperbilirubinemia | 36 (18.4) | 21 (10.3) | 0.02* |
CPAP | 14 (7.1) | 6 (2.9) | 0.09 |
TTN | 1 (0.5) | 2 (1) | > 0.05 |
RDS | 8 (4.1) | 12 (5.9) | 0.55 |
Mechanical ventilation | 15 (7.7) | 19 (9.3) | 0.67 |
Composite respiratory outcome | 25 (12.8) | 24 (11.8) | 0.88 |
Composite neonatal outcome | 61 (31.1) | 48 (23.5) | 0.08 |